VACCINATION AGAINST HPV16/18 INFECTION: IMPACT ON QUALITY OF LIFE

被引：0
|
作者：
Paavonen, J. [1 ]
机构：
[1] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2013年 / 89卷
关键词：
D O I：
10.1136/sextrans-2013-051184.0438
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P2.174
引用
收藏
页码：A141 / A141
页数：1
相关论文
共 50 条
  • [1] Impact of HPV16/18 vaccination on quality of life: A pilot study
    Eriksson, Tiina
    Torvinen, Saku
    Woodhall, Sarah C.
    Lehtinen, Mirjami
    Apter, Dan
    Harjula, Katja
    Hokkanen, Mari
    Rissanen, Pekka
    Paavonen, Jorma
    Lehtinen, Matti
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (05): : 364 - 371
  • [2] Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure
    Beachler, Daniel C.
    Kreimer, Aimee R.
    Schiffman, Mark
    Herrero, Rolando
    Wacholder, Sholom
    Rodriguez, Ana Cecilia
    Lowy, Douglas R.
    Porras, Carolina
    Schiller, John T.
    Jimenez, Silvia
    Struijk, Linda
    Schussler, John
    Hildesheim, Allan
    Gonzalez, Paula
    [J]. CANCER RESEARCH, 2015, 75
  • [3] Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
    Beachler, Daniel C.
    Kreimer, Aimee R.
    Schiffman, Mark
    Herrero, Rolando
    Wacholder, Sholom
    Cecilia Rodriguez, Ana
    Lowy, Douglas R.
    Porras, Carolina
    Schiller, John T.
    Quint, Wim
    Jimenez, Silvia
    Safaeian, Mahboobeh
    Struijk, Linda
    Schussler, John
    Hildesheim, Allan
    Gonzalez, Paula
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (01)
  • [4] How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands
    Coupe, Veerle M. H.
    de Melker, H. E.
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    [J]. VACCINE, 2009, 27 (37) : 5111 - 5119
  • [5] The efficacy of bivalent and tetravalent HPV vaccination against cervical intraepithelial neoplasia and persistent HPV 16 and 18 infection
    Riaz, H.
    Denyer, M.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 : 176 - 177
  • [6] Healthcare spending in the case of a HPV16/18 population-wide vaccination programme
    Vanagas, Giedrius
    Padaiga, Zilvinas
    [J]. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2012, 40 (05) : 406 - 411
  • [7] In silico design of a multi-epitope vaccine against HPV16/18
    Sanami, Samira
    Rafieian-Kopaei, Mahmoud
    Dehkordi, Korosh Ashrafi
    Pazoki-Toroudi, Hamidreza
    Azadegan-Dehkordi, Fatemeh
    Mobini, Gholam-Reza
    Alizadeh, Morteza
    Nezhad, Muhammad Sadeqi
    Ghasemi-Dehnoo, Maryam
    Bagheri, Nader
    [J]. BMC BIOINFORMATICS, 2022, 23 (01)
  • [8] In silico design of a multi-epitope vaccine against HPV16/18
    Samira Sanami
    Mahmoud Rafieian-Kopaei
    Korosh Ashrafi Dehkordi
    Hamidreza Pazoki-Toroudi
    Fatemeh Azadegan-Dehkordi
    Gholam-Reza Mobini
    Morteza Alizadeh
    Muhammad Sadeqi Nezhad
    Maryam Ghasemi-Dehnoo
    Nader Bagheri
    [J]. BMC Bioinformatics, 23
  • [9] HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels
    Fernandes, APM
    Gonçalves, MAG
    Duarte, G
    Cunha, FQ
    Simoes, RT
    Donadi, EA
    [J]. VIROLOGY, 2005, 334 (02) : 294 - 298
  • [10] HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
    Tsang, Sabrina H.
    Schiller, John T.
    Porras, Carolina
    Kemp, Troy J.
    Herrero, Rolando
    Schussler, John
    Sierra, Monica S.
    Cortes, Bernal
    Hildesheim, Allan
    Lowy, Douglas R.
    Cecilia Rodriguez, Ana
    Romero, Byron
    Cuburu, Nicolas
    Shing, Jaimie Z.
    Pinto, Ligia A.
    Sampson, Joshua N.
    Kreimer, Aimee R.
    [J]. NPJ VACCINES, 2022, 7 (01)
12345